Neal Pawar - Mar 1, 2024 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief Operating Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/5/2024, 08:25 PM
Previous filing
Nov 29, 2023
Next filing
Dec 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +144K +13.86% $0.00 1.18M Mar 1, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The RSUs will vest in full as follows: 296,143, 296,143, 296,143 and 296,143 on each of March 1, 2025, 2026, 2027 and 2028.